Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLS
3576
CALL
DELISTED
Staples Inc
SPLS
| $397K | ﹤0.01% |
45,300
-80,600
| -64% | -$727K |
|
3577
PUT
Pentair
PNR
$11.2B
| $396K | ﹤0.01% |
9,381
+4,318
| +85% | +$173K |
|
|
EPAY
3578
DELISTED
Bottomline Technologies Inc
EPAY
| $396K | ﹤0.01% |
16,826
+16,250
| +2,821% | +$409K |
|
3579
PUT
Celanese
CE
$4.82B
| $395K | ﹤0.01% |
4,400
+3,000
| +214% | +$262K |
|
3580
Selective Insurance
SIGI
$5.77B
| $395K | ﹤0.01% |
8,386
-29,871
| -78% | -$1.33M |
|
|
HA
3581
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
| $395K | ﹤0.01% |
8,500
-500
| -6% | -$25.6K |
|
3582
Pathward Financial
CASH
$1.86B
| $394K | ﹤0.01% |
13,392
+11,250
| +525% | +$348K |
|
3583
PUT
Invesco DB Agriculture Fund
DBA
$1.22B
| $394K | ﹤0.01% |
19,900
-7,200
| -27% | -$147K |
|
|
AD
3584
Array Digital Infrastructure
AD
$3.08B
| $394K | ﹤0.01% |
10,548
+6,959
| +194% | +$286K |
|
|
DNKN
3585
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $394K | ﹤0.01% |
7,200
-45,000
| -86% | -$2.41M |
|
3586
CRA International
CRAI
$1.14B
| $393K | ﹤0.01% |
11,128
+5,206
| +88% | +$182K |
|
3587
Seres Therapeutics
MCRB
$47.9M
| $393K | ﹤0.01% |
1,747
+1,545
| +765% | +$314K |
|
3588
ProShares UltraShort QQQ
QID
$253M
| $393K | ﹤0.01% |
257
+247
| +2,470% | +$408K |
|
3589
Coherus Oncology
CHRS
$194M
| $391K | ﹤0.01% |
18,511
+16,302
| +738% | +$401K |
|
|
CSGS
3590
DELISTED
CSG Systems International
CSGS
| $391K | ﹤0.01% |
10,323
-25,543
| -71% | -$1.08M |
|
3591
Knowles
KN
$3.36B
| $391K | ﹤0.01% |
20,558
+10,387
| +102% | +$190K |
|
|
HIMX
3592
PUT
Himax Technologies
HIMX
$2.4B
| $390K | ﹤0.01% |
42,800
-12,900
| -23% | -$87.4K |
|
3593
iShares Russell 2000 Value ETF
IWN
$14.5B
| $390K | ﹤0.01% |
3,300
+2,897
| +719% | +$344K |
|
3594
PUT
Ventas
VTR
$47.3B
| $390K | ﹤0.01% |
6,000
-5,300
| -47% | -$330K |
|
|
BSTC
3595
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $390K | ﹤0.01% |
7,125
+4,725
| +197% | +$250K |
|
3596
iShares MSCI Singapore ETF
EWS
$1.06B
| $389K | ﹤0.01% |
17,043
-6,978
| -29% | -$153K |
|
3597
PUT
PTC
PTC
$16B
| $389K | ﹤0.01% |
7,400
-1,400
| -16% | -$74K |
|
|
FTD
3598
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $389K | ﹤0.01% |
19,345
+18,782
| +3,336% | +$427K |
|
|
CONN
3599
DELISTED
Conn's Inc.
CONN
| $388K | ﹤0.01% |
44,366
+36,880
| +493% | +$371K |
|
|
MLNX
3600
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $387K | ﹤0.01% |
7,600
-33,300
| -81% | -$1.58M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.